Delivery Order SPE2DX22D0110-SPE2D825F5WPQ
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,415.48, is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, worth $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,101.60, is a delivery order for pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other critical medical commodities. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $84,927.67, is for the provision of various pharmaceutical products and medical supplies to support military healthcare programs. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award, valued at $1,033.75, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,604.62 and is a delivery order with a firm fixed price. The contract covers the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Amerisourcebergen holds a significant Indefinite...
- This federal contract award, valued at $24,738.74, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, which is valued at $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
- This federal contract award, valued at $11,193.44, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to supply a comprehensive range of...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,775.64, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA, worth up to $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of a wide range of medical products and supplies to support military healthcare programs and other federal agencies. The contract, valued at $1,217.58, is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $145,624.08, covers the delivery of a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs....
- SPE2DX22D0110Indefinite Delivery Contract
- SPE2DX22D0110-SPE2D825F5WPQDelivery Order
This federal contract award is a delivery order valued at $1,175.76, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the provision of a range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for delivering a comprehensive suite of essential medical commodities to the military. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Loading... | ||||